No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - General
Guangdong Jiaying Pharmaceutical Co., Ltd. is engaged in the comprehensive process of researching, developing, manufacturing, and marketing traditional Chinese medicines. Its operations span a vast international territory, encompassing Mainland China, Taiwan, Hong Kong, Macao, Southeast Asia, Europe, and the United States. The company primarily offers therapeutic solutions for a variety of health issues, such as throat conditions, common colds, orthopedic ailments, rheumatic diseases, gynecological disorders, conditions requiring heat-clearing, and gastrointestinal problems. These medical preparations are provided in numerous formats, including powders, tablets, capsules, granules, and pills. The distribution of its product line occurs through both independent agencies and direct sales points. The firm's operational hub is situated in Meizhou, China.
www.gdjyzy.com.cnNo one on the platform currently holds 002198.SZ.
No tracked institution reports a position in 002198.SZ as of their last filing.
No one on the platform has traded 002198.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002198.SZGuangdong Jiaying Pharmaceutical Co., Ltd | $3.63 | -0.27% | $1.8B | — |
| 002219.SZNew Journey Health Technology Group Co.,LTD | $2.11 | +0.48% | $7.3B | — |
| 002262.SZJiangsu Nhwa Pharmaceutical Co., Ltd. | $21.59 | -0.28% | $21.9B | — |
| 002275.SZGuilin Sanjin Pharmaceutical Co., Ltd. | $12.09 | -0.41% | $7.1B | — |
| GIS.DEGilead Sciences, Inc. | $126.24 | +0.06% | $156.7B | — |
| OGNOrganon & Co. | $13.66 | +0.11% | $3.6B | — |
| OPHLFOno Pharmaceutical Co., Ltd. | $15.00 | +0.00% | $7.0B | — |
Source: Financial Modeling Prep · peers by sector/industry